Current position:Home >Product >
4,7,10,13-Tetraoxahexadecanedioic acid, 2,2,15,15-tetramethyl-, compd. with N,N-diethylethanamine
4,7,10,13-Tetraoxahexadecanedioic acid, 2,2,15,15-tetramethyl-, compd. with N,N-diethylethanamine(138213-56-6)
- Name: 4,7,10,13-Tetraoxahexadecanedioic acid, 2,2,15,15-tetramethyl-, compd. with N,N-diethylethanamine
- Synonyms:
- Molecular Formula:C16H30O8.xC6H15N
- Molecular Weight:
- CAS Registry Number:138213-56-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.138213-56-6 4,7,10,13-Tetraoxahexadecanedioic acid, 2,2,15,15-tetramethyl-, compd. with N,N-diethylethanamine
Assay:99.90% Appearance:solid or liquid Package:Foil bag; Drum; Plastic bottle Storage:in sealed air resistant place Transportation:by sea or air Application:Pharma;Industry;Agricultural
Min. Order:0
Supplier:Kono Chem Co.,Ltd [
China (Mainland)]
Other Product
- 138212-28-9/6-Octen-1-yne, 8-methoxy-, (E)-
- 138212-29-0/Carbamic acid, [(4-methylphenyl)sulfonyl]-, 2,3-butadienyl ester
- 138212-53-0/3-Butyn-1-ol, 2-bromo-4-[(1,1-dimethylethyl)dimethylsilyl]-, (S)-
- 138212-54-1/Silane, (1,1-dimethylethyl)dimethyl(oxiranylethynyl)-, (R)-
- 138212-55-2/3-Butyn-2-ol, 4-[(1,1-dimethylethyl)dimethylsilyl]-1-(phenylmethoxy)-, (R)-
- 138213-21-5/5(4H)-Thiazolone, 2-(methylthio)-4-[(4-nitrophenyl)methylene]-
- 138213-22-6/5(4H)-Thiazolone, 4-(2-furanylmethylene)-2-(methylthio)-
- 138213-44-2/2,4(1H,3H)-Pyrimidinedione, 5-ethyl-1-[(2-hydroxyethoxy)methyl]-6-(phenylmethyl)-
- 138213-45-3/Acetamide, N-(9,10-dimethoxy-1-anthracenyl)-
- 138213-48-6/2(1H)-Quinolinone, 4,6-dimethoxy-1-methyl-3-(3-methyl-2-butenyl)-
- 138213-49-7/2(1H)-Quinolinone, 6-chloro-4-methoxy-1-methyl-3-(3-methyl-2-butenyl)-
- 138213-50-0/2(1H)-Quinolinone, 6-bromo-4-methoxy-1-methyl-3-(3-methyl-2-butenyl)-
- 138213-51-1/Disiloxane, 3,3-dichloro-1-methyl-1,1-diphenyl-
- 138213-52-2/3H-Indolium, 2-[2-(1H-benzimidazol-4-yl)ethenyl]-5-methoxy-1,3,3-trimethyl-, (Z)-
- 138213-53-3/2(5H)-Furanone, 4-[[[4-(bromodifluoromethoxy)phenyl]methyl]thio]-3-chloro-5-hydroxy-
- 138213-55-5/Propanoic acid, 3,3'-[1,13-tridecanediylbis(oxy)]bis[2,2-dimethyl-, compd. with N,N-diethylethanamine
- 138213-56-6/4,7,10,13-Tetraoxahexadecanedioic acid, 2,2,15,15-tetramethyl-, compd. with N,N-diethylethanamine
- 138213-62-4/3,6,9,12-Tetraazatricosanedioic acid, 3,6,9-tris(carboxymethyl)-11-oxo-
- 138214-74-1/Ethanaminium, N,N,N-trimethyl-2-[(1-oxo-2-phenylpropyl)thio]-
- 138214-66-1/2H-1-Benzopyran, 6-(chloromethyl)-2,2-dimethyl-
- 138214-55-8/Spiro[cyclohexane-1,7'-[1,4]diazabicyclo[3.2.1]octan]-4-one, 3-hydroxy-4'-methyl-2'-[2-[4-(3-methylbutoxy)phenyl]ethenyl]-
- 138214-54-7/Spiro[cyclohexane-1,7'-[1,4]diazabicyclo[3.2.1]octan]-4-one, 4'-methyl-2'-[2-[4-(3-methylbutoxy)phenyl]ethenyl]-
- 138214-53-6/Spiro[cyclohexane-1,7'-[1,4]diazabicyclo[3.2.1]octane]-3,4-diol, 4'-methyl-2'-[2-[4-[(3-methyl-2-butenyl)oxy]phenyl]ethenyl]-
- 138214-52-5/Spiro[cyclohexane-1,7'-[1,4]diazabicyclo[3.2.1]octan]-4-ol, 4'-methyl-2'-[2-[4-[(3-methyl-2-butenyl)oxy]phenyl]ethenyl]-, trans-
- 138214-51-4/Spiro[cyclohexane-1,7'-[1,4]diazabicyclo[3.2.1]octan]-4-ol, 4'-methyl-2'-[2-[4-[(3-methyl-2-butenyl)oxy]phenyl]ethenyl]-, cis-
- 138214-50-3/Spiro[cyclohexane-1,7'-[1,4]diazabicyclo[3.2.1]octan]-4-one, 3-hydroxy-2'-[2-(4-hydroxyphenyl)ethenyl]-4'-methyl-
- 138214-49-0/Spiro[cyclohexane-1,7'-[1,4]diazabicyclo[3.2.1]octan]-4-one, 2'-[2-(4-hydroxyphenyl)ethenyl]-4'-methyl-
- 138214-48-9/Spiro[cyclohexane-1,7'-[1,4]diazabicyclo[3.2.1]octan]-4-one, 4'-methyl-2'-[[4-[(3-methyl-2-butenyl)oxy]phenyl]methyl]-
- 138214-47-8/Spiro[cyclohexane-1,7'-[1,4]diazabicyclo[3.2.1]oct[2]en]-4-one, 4'-methyl-2'-[[4-[(3-methyl-2-butenyl)oxy]phenyl]methyl]-
- 138214-46-7/Spiro[cyclohexane-1,7'-[1,4]diazabicyclo[3.2.1]octan]-4-one, 3-hydroxy-4'-methyl-2'-[2-[4-[(3-methyl-2-butenyl)oxy]phenyl]ethenyl]-